IP Library Granted Patent US 9,719,085
Granted Patent B2
US 9,719,085 · App. 14/464,011 · Granted Aug 1, 2017

Trans-acting RNA switches

Inventors: Scott A. Tenenbaum (Selkirk, NY); Francis J. Doyle, II (Albany, NY); Ajish George (Timonium, MD); Christopher Zaleski (Huntington, NY)
Assignee: The Research Foundation of the University of New York
C12N15/113C12N15/111G01N33/5005G01N33/5308C12N2310/113C12N2310/141C12N2310/531C12N2320/50C12N2330/51
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,719,085
App. No.
14/464,011
Granted
Aug 1, 2017
Kind
B2
Abstract

Disclosed are RNA constructs which function to activate or inactivate a biological process, e.g., may be designed for attachment to a polypeptide coding region. Such RNA constructs modulate translation of a polypeptide from the coding region in response to the presence of a target polynucleotide in an expression environment. Such RNA constructs include a weakened stem-loop structure which, when bound to the target polynucleotide, assumes stem-loop secondary structure and associates with an RNA binding protein. Association with the RNA binding protein modulates translation of the polypeptide coding region. Such RNA constructs also have three-way junction joining regions 3′ and 5′ of the stem-loop structure.

Claims (25)

1. A method for modulating translation of a polypeptide coding region comprising the step of:

(A) providing a translatable RNA construct comprising a polypeptide coding region ligated to a non-naturally occurring RNA comprising a continuous sequence of ribonucleotide bases, the continuous sequence of ribonucleotide bases defining:

a stem-loop structure which associates with an RNA binding protein present in an expression environment to modulate translation of the polypeptide coding region when the RNA construct is in a stem-loop conformation;

simulated, three way junction joining regions 3′ and 5′ of the stem-loop structure;

a first region 5′ of the 5′ joining region comprising bases complementary to a 3′ region of a target polynucleotide;

a second region 3′ of the 3′ joining region comprising bases complementary to a 5′ region of the target polynucleotide;

the base sequence of the first and second regions being selected to hybridize with complementary bases on the target polynucleotide spaced apart by an intermediate region on the target polynucleotide defining another three way junction joining region; and

(B) introducing the translatable RNA construct into an expression system, whereby,

in the absence of the target polynucleotide, the construct assumes a conformation inhibiting association with the RNA binding protein, and

in the presence of the target polynucleotide, the construct assumes a stem-loop conformation promoting association with the RNA binding protein.

2. The method of claim 1 , wherein at least one base in the stem of the stem-loop structure is mismatched with its potential binding partner so as to reduce the stability of the stem-loop structure.

3. The method of claim 1 , wherein a joining region comprises no more than about 10 nucleotides.

4. The method of claim 1 , wherein step (B) is effected by transfecting a DNA encoding the translatable RNA construct.

5. The method of claim 1 , wherein the target polynucleotide is characteristic of a pathogen.

6. The method of claim 1 , wherein the target polynucleotide is expressed preferentially in a cell type of a multicellular organism.

7. The method of claim 6 , wherein the cell type is a neoplastic cell.

8. The method of claim 1 , comprising the additional step of introducing the target polynucleotide into the expression environment.

9. The method of claim 1 , wherein the expression environment is a cell and the polypeptide coding region encodes a polypeptide lethal to the cell.

10. The method of claim 9 , wherein the cell is an infected cell or a neoplastic cell, and the target polynucleotide is expressed by the neoplastic cell or by an organism infecting the cell.

11. The method of claim 1 , wherein the polypeptide coding region comprises a sequence encoding an enzyme or pore-forming protein.

12. The method of claim 1 , wherein the polypeptide coding region encodes a detectable marker.

13. The method of claim 12 , wherein the detectable marker is fluorescent.

14. The method of claim 1 , wherein translation of the coding region is suppressed when the RNA binding protein binds to the stem-loop structure.

15. The method of claim 1 , wherein translation of the coding region is promoted when the RNA binding protein binds to the stem-loop structure.

16. The method of claim 1 , wherein the construct comprises more than one stem-loop structure.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 31, 2019
From: TENENBAUM, SCOTT A.; DOYLE, FRANCIS J., II; GEORGE, AJISH; ZALESKI, CHRISTOPHER
To: THE RESEARCH FOUNDATION OF THE UNIVERSITY OF NEW YORK
Reel/Frame 049330/0100 →
CONFIRMATORY LICENSE Recorded Nov 3, 2014
From: THE RESEARCH FOUNDATION FOR THE STATE UNIVERSITY OF NEW YORK
To: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
Reel/Frame 034117/0375 →
Continuity (3)
Division 13321816
Provisional Application 61180670 · May 22, 2009
Related Publication 20150045414A1 · Feb 12, 2015